Literature DB >> 17343081

Protein-losing enteropathy in Crohn's disease.

Marc Ferrante1, Freddy Penninckx, Gert De Hertogh, Karel Geboes, Andre D'Hoore, Maja Noman, Séverine Vermeire, Paul Rutgeerts, Gert Van Assche.   

Abstract

Protein-losing enteropathy (PLE) is a rare but severe complication of Crohn's disease (CD) and hypoalbuminemia can be one of the presenting symptoms of this illness. The diagnosis of PLE can only be made after exclusion of malnutrition and liver or kidney failure. Significant intestinal leakage can be caused by mucosal injury, increased lymphatic pressure or dilated lymphatics and has been reported in a large number of diseases. The protein-losing can be diagnosed by assessing the excretion of different radiolabeled macromolecules in the faeces or by the clearance of alpha-1-antitrypsine in stools. The primary approach should be the optimization of the nutritional status. Medical treatment of the underlying disease is primordial. In other cases surgical resection of the most affected areas is inevitable. We report a case of a 21-year-old male with a 4 year history of CD, who developed significant hypoproteinemia with pitting oedema, initially in the absence of any other sign of severe disease activity. A "Cr-chloride albumin excretion confirmed our hypothesis of protein-losing enteropathy. Because of sub-obstruction signs some months later, a laparotomy was performed which revealed a severely affected loop with dilatation of the proximal jejunum. Interestingly, multiple large lymph nodes and dilated lymphatics were seen. A partial jejunal resection was performed for stricturing Crohn's disease. Histology showed severe mesenteric granulomatosis, dilated lymph vessels and granulomatous vasculitis. After the resection our patient improved without further albumin infusions and the oedema resolved.

Entities:  

Mesh:

Year:  2006        PMID: 17343081

Source DB:  PubMed          Journal:  Acta Gastroenterol Belg        ISSN: 1784-3227            Impact factor:   1.316


  9 in total

Review 1.  Growth Delay in Inflammatory Bowel Diseases: Significance, Causes, and Management.

Authors:  Kerry Wong; Daniela Migliarese Isaac; Eytan Wine
Journal:  Dig Dis Sci       Date:  2021-01-12       Impact factor: 3.199

Review 2.  Where are all the Mycobacterium avium subspecies paratuberculosis in patients with Crohn's disease?

Authors:  Ellen S Pierce
Journal:  PLoS Pathog       Date:  2009-03-27       Impact factor: 6.823

3.  Mathematical modelling to restore circulating IGF-1 concentrations in children with Crohn's disease-induced growth failure: a pharmacokinetic study.

Authors:  A Rao; J F Standing; S Naik; M O Savage; I R Sanderson
Journal:  BMJ Open       Date:  2013-05-28       Impact factor: 2.692

4.  A case of protein supplement effect in protein-losing enteropathy.

Authors:  Hyun Jeong Lee; Mi Yong Rha; Young Yun Cho; Eun Ran Kim; Dong Kyung Chang
Journal:  Clin Nutr Res       Date:  2012-07-26

5.  Protein-losing enteropathy in ulcerative colitis.

Authors:  Ryan Ungaro; Mark W Babyatsky; Hongfa Zhu; Jeffrey S Freed
Journal:  Case Rep Gastroenterol       Date:  2012-04-11

6.  Disseminated cytomegalovirus infection and protein losing enteropathy as presenting feature of pediatric patient with Crohn's disease.

Authors:  Murat Cakir; Safak Ersoz; Ulas Emre Akbulut
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2015-03-30

7.  An unusual cause of protein losing enteropathy in a 2.5-year-old girl: meso-intestinal fibrosis.

Authors:  Fatemeh Mahjoub; Mehri Najafi Sani; Ahmad Khaleghnejad Tabari; Maryam Monajemzadeh; Saeed Zandieh
Journal:  European J Pediatr Surg Rep       Date:  2013-05-31

8.  Protein-Losing Enteropathy in Crohn's Disease: Two Unusual Cases.

Authors:  Samira Samant; Danielle R Lyon; Nisar Asmi; Pinky Jha
Journal:  Cureus       Date:  2021-11-12

Review 9.  ANCA-associated vasculitis with protein-losing enteropathy is characterized by hypocomplementemia.

Authors:  Manaka Goto; Yumi Tsuchida; Keigo Terada; Hideyuki Takahashi; Yusuke Sugimori; Toshihiko Komai; Yukiko Iwasaki; Hirofumi Shoda; Keishi Fujio
Journal:  Rheumatol Int       Date:  2021-06-22       Impact factor: 3.580

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.